Double-blind crossover study of high-dose cetirizine in cholinergic urticaria

Dermatology

Volumn 193, Issue 4, 1996, Pages 324-327

  Zuberbier, T ^a   Münzberger, Ch ^b   Haustein, U ^b   Trippas, E ^c   Burtin, B ^c   Mariz, S D ^c   Henz, B M ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UCB PHARMA   (Belgium)

Author keywords

Antihistamines; Cholinergic urticaria

Indexed keywords

ANTIALLERGIC AGENT; ANTIHISTAMINIC AGENT; CETIRIZINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ERYTHEMA; FEMALE; HUMAN; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; SYMPTOM; URTICARIA;

EID: 0030445335     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000246281     Document Type: Article

References (17)

1. Hirschmann JV. Lawlor F, English JSC, Louback JB. Winkelmann RK, Greaves MW: Cholinergic urticaria. Arch Dermatol 1987: 123:462-467.
2. Zuberbier T, Althaus C, Chantraine-Hess S. Czarnetzki BM: Prevalence of cholinergic urticaria in young adults. J Am Acad Dermatol 1994;31:978-981.
3. Czarnetzki BM: Urticaria. Berlin, Springer. 1986.
4. Herxheimer A: The nervous pathway mediating cholinergic urticaria. J Clin Sci 1956:15: 195-204.
5. Shelley WB, Shelley ED, Ho AKS: Cholinergic urticaria: Acetylcholine-receptor-depen-dent immediate-type hypersensitivity reaction to copper. Lancet 1983:843-846.
6. Soter HA. Wassermann SI, Austen KF. McFadden ER: Release of mast cell mediators and alterations in lung functions in patients with cholinergic urticaria. N Engl J Med 1980:302: 604-608.
7. Haas N. Motel K, Czarnetzki BM: Comparative immunoreactivity of the eosinophil constituents M BP and ECP in different types of urticaria. Arch Dermatol Res 1995:287:180-185.
8. Cap J-P. Schwanitz HJ. Czarnetzki BM: Die Wirkung von Ketotifen bei der Urticaria fac-titia und der Urticaria cholinergica im gekreuzten Doppelblindversuch. Hautarzt 1985:36: 509-511.
9. McClean SP. Arrcaza EE. Lett-Brown MA. Grant JA: Refractory cholinergic urticaria successfully treated with ketotifen. J Allergy Clin Immunol 1989:83:738-741.
10. 1-receptor antagonists). J Allergy Clin Immunol 1992:90:705-715.
11. Zuberbier T. Aberer W. Burtin M. Rihoux J-P, Czarnetzki BM: Efficacy of cetirizine in cholinergic urticaria. Acta Derm Venercol (Stoekh) 1995:75:147-149.
12. Czarnetzki BM: Ketotifen in cholinergic urticaria. J Allergy Clin Immunol 1990:86: 138-139.
13. Kontou-Fili K. Maniatakou G, Demaka P. Gon anakis M. Palaiogolos G, Aroni K: Therapeutic effects of cetirizine 2HCI in delayed pressure urticaria: Clinicopathologic findings. J Am Acad Dermatol 1991;24:1090-1093.
14. Czarnetzki BM: Mechanisms and mediators in urticaria. Semin Dermatol 1987:6:272-285.
15. Wahlgren GF: Pathophysiology of itching in urticaria and atopic dermatitis. Allergy 1992; 47:65-75.
16. Foreman JC, Jordan CC, Oehme P. Renner H: Structure-activity relationships for some substance P-related peptides that cause wheal and flare reaction in human skin. J Physiol 1983; 335:449-465.
17. Estes SA. Young CU: Delayed pressure urticaria. J Am Acad Dermatol 1981;5:25-31